Decrease in ATP biosynthesis and dysfunction of biological membranes. Two possible key mechanisms of phenoptosis

Biochemistry (Moscow)

Volumn 79, Issue 10, 2014, Pages 1056-1068

  Rzheshevsky, A V ^a  

^a Center for Rehabilitation Medicine   (Ukraine)

Author keywords

AMP activated protein kinase; Apoptosis; Bio membranes dysfunction; Endoplasmic reticulum; Fatty acids; Insulin; Leptin; Mitochondria; mTOR; Oxidative stress; Phenoptosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; FAT10 PROTEIN, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN;

AGING; ANIMAL; APOPTOSIS; CELL MEMBRANE; GENETICS; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLIC SYNDROME X; METABOLISM; MITOCHONDRION; NERVOUS SYSTEM; NERVOUS SYSTEM FUNCTION; PATHOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CELL MEMBRANE; HUMANS; HYPOTHALAMUS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICE, KNOCKOUT; MITOCHONDRIA; NERVOUS SYSTEM; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NF-KAPPA B; UBIQUITINS;

EID: 84910123337     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297914100071     Document Type: Review

References (110)

1. Anisimov, V. N. (2008) Molecular and Physiological Mechanisms of Aging [in Russian], 2nd Edn., Nauka, St. Petersburg.
2. Skulachev, V. P. (1997) Aging is a specific biological function rather than the result of a disorder in complex living systems: biochemical evidence in support of Weisman's hypothesis, Biochemistry (Moscow), 62, 1191-1195.
3. Skulachev, V. P. (1999) Phenoptosis: programmed death of an organism, Biochemistry (Moscow), 64, 1418-1426.
4. Dontsov, V. I., Krut'ko, V. N., Mrikaev, B. M., and Ukhanov, S. V. (2006) Active oxygen species as a system: their importance in physiology, pathology and natural aging, Trudy ISA RAN, 19, 50-69.
5. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817-825.
6. Lushnikov, E. F., Abrosimov, A. Yu., Gabai, V. L., Saenko, A. S., and Dorosevich, A. E. (2001) Cell Death (Apoptosis) [in Russian], Meditsina, Moscow.
7. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest, Cell, 76, 1013-1023.
8. Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. (1996) Involvement of the cyclin- dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts, Proc. Natl. Acad. Sci. USA, 93, 13742-13747.
9. Chumakov, P. M. (2007) Versatile functions of p53 protein in multicellular organism, Biochemistry (Moscow), 72, 1399-1421.
10. Ushakov, A. V., Russel, M. V., and Borisov, A. B. (2005) Disruptions of energetic metabolism in cardiomyocytes in pathogenesis of ischemic damage of myocardium in patients with diabetes mellitus, Mezhdunarod. Med. Zh., 11, 6-11.
11. Skulachev, V. P. (2001) Phenomenon of biological death. Mitochondria, cells and organs: the role of active oxygen species, Soros Obrazovat. Zh., 7, 4-10.
12. Dilman, V. M. (1982) Big Biological Clock [Russian translation], Znanie, Moscow.
13. Moraes, J. C., Coope, A., Morari, J., Cintra, D. E., Roman, E. A., Pauli, J. R., Romanatto, T., Carvalheira, J. B., Oliveira, A. L., Saad, M. J., and Velloso, L. A. (2009) High-fat diet induces apoptosis of hypothalamic neurons, PLoS ONE, 4, 1-11.
14. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Muller, C., Carling, D., and Kahn, B. B. (2002) Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase, Nature, 15, 339-343.
15. Unger, R. H. (2005) Hyperleptinemia: protecting the heart from lipid overload, Hypertension, 45, 1031-1034.
16. Viollet, B., Guigas, B., Leclerc, J., Hebrard, S., Lantier, L., Mounier, R., Andreelli, F., and Foretz, M. (2009) AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives, Acta Physiol. (Oxf.), 196, 81-98.
17. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., and Cantley, L. C. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress, Proc. Natl. Acad. Sci. USA, 101, 3329-3335.
18. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K. L. (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling, Nat. Cell Biol., 4, 648-657.
19. Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., and Levine, A. J. (2007) The regulation of AMPK β1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways, Cancer Res., 67, 3043-3053.
20. Levine, A. J., Feng, Z., Mak, T. W., You, H., and Jin, S. (2006) Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways, Genes Dev., 20, 267-275.
21. Minokoshi, Y., and Kahn, B. B. (2003) Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle, Biochem. Soc. Trans., 31, 196-201.
22. Caro, J. F., Sinha, M. K., Kolaczynski, J. W., Zhang, P. L., and Considine, R. V. (1996) Leptin: the tale of an obesity gene, Diabetes, 45, 1455-1462.
23. Kishkun, A. A. (2008) Biological Age and Aging. Possibilities for Determination and Ways for Correction [in Russian], GEOTAR-Media, Moscow.
24. Loh, K., Fukushima, A., Zhang, X., Galic, S., Briggs, D., Enriori, P. J., Simonds, S., Wiede, F., Reichenbach, A., Hauser, C., Sims, N. A., Bence, K. K., Zhang, S., Zhang, Z. Y., Kahn, B. B., Neel, B. G., Andrews, Z. B., Cowley, M. A., and Tiganis, T. (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance, Cell Metab., 14, 684-699.
25. Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, D., Hotamisligil, G., and Van Obberghen, E. (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice, J. Biol. Chem., 276, 47944-47949.
26. Hosoi, T., Sasaki, M., Miyahara, T., Hashimoto, C., Matsuo, S., Yoshii, M., and Ozawa, K. (2008) Endoplasmic reticulum stress induces leptin resistance, Mol. Pharmacol., 74, 1610-1619.
27. Castro, G., Areias, M. F., Weissmann, L., Quaresma, P. G., Katashima, C. K., Saad, M. J., and Prada, P. O. (2013) Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats, FEBS Open Biol., 11, 443-449.
28. Fukuda, H., Iritani, N., Sugimoto, T., and Ikeda, H. (1999) Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats, Eur. J. Biochem., 260, 505-511.
29. Benoit, S. C., Clegg, D. J., Seeley, R. J., and Woods, S. C. (2004) Insulin and leptin as adiposity signals, Recent Prog. Horm. Res., 59, 267-285.
30. Unger, R. H. (2003) Mini-review: Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome, Endocrinology, 144, 5159-5165.
31. Perez-Carreras, M. (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steato-hepatitis, Hepatology, 38, 999-1007.
32. Mannaerts, G. P., Van Veldhoven, P. P., and Casteels, M. (2000) Peroxisomal lipid degradation via β- and α-oxidation in mammals, Cell Biochem. Biophys., 32, 73-87.
33. Bergamini, C. M., Gambetti, S., Dondi, A., and Cervellati, C. (2004) Oxygen, reactive oxygen species and tissue damage, Curr. Pharm. Des., 10, 1611-1626.
34. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125-1131.
35. Robertson, G., Leclercq, I., and Farrell, G. C. (2001) Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P450 enzymes and oxidative stress, Am. J. Physiol. Gastrointest. Liver Physiol., 281, 1135-1139.
36. Caldwell, S. H. (1999) Mitochondrial abnormalities in nonalcoholic steatohepatitis, J. Hepatol., 31, 430-434.
37. Lesnefsky, E. J., Chen, Q., Slabe, T. J., Stoll, M. S., Minkler, P. E., Hassan, M. O., Tandler, B., and Hoppel, C. L. (2004) Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin, Am. J. Physiol. Heart Circ. Physiol., 287, 258-267.
38. Skulachev, V. P. (1998) Alternative ways of cell respiration, Soros Obrazovat. Zh., 8, 2-7.
39. Sudakov, N. P., Nikiforov, S. B., Konstantinov, Yu. M., Yakubov, L. A., Novikova, N. A., and Karamysheva, A. N. (2006) Mechanisms of participation of mitochondria in the development of pathological processes, accompanied by ischemia and reperfusion, Byul. VSNTs SO RAMN, 5, 332-336.
40. Solmi, R., Pallotti, F., Rugolo, M., Genova, M. L., Estornell, E., Ghetti, P., Pugnaloni, A., Biagini, G., Rizzoli, C., and Lenaz, G. (1994) Lack of major mitochondrial bioenergetic changes in cultured skin fibroblasts from aged individuals, Biochem. Mol. Biol. Int., 33, 477-484.
41. Ozawa, T. (1997) Oxidative damage and fragmentation of mitochondrial DNA in cellular apoptosis: a review, Biosci. Rep., 17, 237-250.
42. Johnson, M. L., Robinson, M. M., and Nair, K. S. (2013) Skeletal muscle aging and the mitochondrion, Trends Endocrinol. Metab., 24, 247-256.
43. Lee, H. C., and Wei, Y. H. (2012) Mitochondria and aging, Adv. Exp. Med. Biol., 942, 311-327.
44. Wang, D., Wei, Y., and Pagliassotti, M. J. (2006) Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis, Endocrinology, 147, 943-951.
45. Shulpekova, Yu. O. (2012) Pathogenetic importance of lipids in nonalcoholic fat disease of the liver, Ross. Zh. Gastroenterol. Gepatol. Koloproktol., 1, 45-56.
46. Czaja, M. J. (2003) The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death, Am. J. Physiol. Gastrointest. Liver Physiol., 284, 875-879.
47. Cazanave, S., and Gores, G. (2010) Mechanisms and clinical implications of hepatocyte lipoapoptosis, Clin. Lipidol., 5, 71-85.
48. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., and Ron, D. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1, Science, 287, 664-666.
49. Yamamoto, K., Ichijo, H., and Korsmeyer, S. J. (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M, Mol. Cell Biol., 19, 8469-8478.
50. Malhi, H., Bronk, S. F., Werneburg, N. W., and Gores, G. (2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis, J. Biol. Chem., 281, 12093-12101.
51. Yamaguchi, H., and Wang, H. G. (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells, J. Biol. Chem., 279, 45495-45502.
52. Xu, C., Bailly-Maitre, B., and Reed, J. C. (2005) Endoplasmic reticulum stress: cell life and death decisions, J. Clin. Invest., 115, 2656-2664.
53. Vasyuk, Yu. A., Kulikov, K. G., Kudryakov, O. N., Krikunova, O. V., and Sadulaeva, I. A. (2007) Secondary mitochondrial dysfunction at acute coronary syndrome, Rational Pharmacother. Cardiol., 1, 41-47.
54. Aleksandrov, A. (2005) Clinical horizons of cardioprotection: "calcium trace" of trimetazidine, Consilium Med., 7, 757-763.
55. Bolli, R. (1990) Mechanism of myocardial "stunning, Circulation, 82, 723-738.
56. Bolli, R. (1998) Causative role of oxy-radicals in myocardial stunning: a proven hypothesis, Basic Res. Cardiol., 93, 156-162.
57. Sun, J. Z., Tang, X. L., Park, S. W., Qiu, Y., Turrens, J. F., and Bolli, R. (1996) Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs, J. Clin. Invest., 97, 562-576.
58. Novitsky, V. V., Ryazantseva, N. V., Stepovaya, E. A., Fedorova, T. S., Kravets, E. B., Ivanov, V. V., Zhavoronok, T. V., Chasovskikh, N. Yu., Chudakova, O. M., Butusova, V. N., and Yakovleva, N. M. (2006) Molecular disturbances of erythrocyte membrane in pathology of different genesis represent a typical reaction of the organism: contours of the problem, Byul. Sib. Med., 2, 62-69.
59. Masoro, E. J., Katz, M. S., and McMahan, C. A. (1989) Evidence for the glycation hypothesis of aging from the food-restricted rodent model, J. Gerontol., 44, 20-22.
60. Zalevskaya, A. G., and Patrakeeva, E. M. (2008) Metabolic regulation and cAMP-dependent protein kinase (AMPK): enemy or ally? Sakharnyi Diabet, 4, 12-17.
61. Vladimirov, Yu. A. (2000) Biological membranes and non-programmed cell death, Soros Obrazovat. Zh., 6, 2-9.
62. Wood, W. G., Schroeder, F., Igbavboa, U., Avdulov, N. A., and Chochina, S. V. (2002) Brain membrane cholesterol domains, aging and amyloid β-peptides, Neurobiol. Aging, 23, 685-694.
63. Tereshina, E. V. (2007) Role of fatty acids in the development of age-related oxidative stress, Uspekhi Gerontol., 20, 59-65.
64. Titov, V. N. (2012) Development in phylogeny, etiology and pathogenesis of insulin resistance syndrome. Differences from type 2 diabetes, Vestnik RAMN, 4, 65-73.
65. Kotyk, A., and Yanachek, K. (1980) Membrane Transport [Russian translation], Mir, Moscow.
66. Brownlee, M. (1995) Advanced protein glycosylation in diabetes and aging, Annu. Rev. Med., 46, 223-234.
67. Banerjee, T., and Kuypers, F. A. (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells, Br. J. Haematol., 124, 391-402.
68. Wahid, S. T., Marshall, S. M., and Thomas, T. H. (2001) Increased platelet and erythrocyte external cell membrane phosphatidylserine in type 1 diabetes and microalbuminuria, Diabetes Care, 24, 2001-2003.
69. Titov, V. N. (2000) Common features of atherosclerosis and inflammation: specificity of atherosclerosis as inflammation process (hypothesis), Klin. Lab. Diagn., 4, 3-10.
70. Titov, V. N. (1999) Disruption of saturated fatty acids transport into cells in pathogenesis of essential hypertension (review), Klin. Lab. Diagn., 2, 3-9.
71. Pamplona, R., Portero-Otin, M., Ruiz, C., Gredilla, R., Herrero, A., and Barja, G. (2000) Double bond content of phospholipids and lipid peroxidation negatively correlate with maximum longevity in the heart of mammals, Mech. Ageing Dev., 112, 169-183.
72. Illarioshkin, S. N. (2012) Disruptions of cellular energetic in nervous system diseases, Nervnye Bolezni, 1, 34-38.
73. Vasenina, E. E., and Levin, O. S. (2013) Oxidative stress in pathogenesis of neurodegenerative diseases: possibilities of a therapy, Sovrem. Terap. Psikhiatr. Nevrol., 3/4, 39-46.
74. Sudakov, N. P., Byvaltsev, V. A., Nikiforov, S. B., Sorokovikov, S. B., Klimenkov, I. V., and Konstantinov, Yu. M. (2010) Dysfunction of mitochondria in neurodegenerative diseases, Zh. Nevrol. Psikhiatr., 9, 87-91.
75. Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., Jr., and Yaffe, K. (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study, BMJ, 330, 1360.
76. Obeid, L. M., and Hannun, Y. A. (2003) Ceramide, stress, and a "LAG" in aging, Sci. Aging Knowledge Environ., 39, PE27.
77. Obeid, L. M., and Hannun, Y. A. (2008) Principles of bioactive lipid signaling: lessons from sphingolipids, Nat. Rev. Mol. Cell. Biol., 9, 139-150.
78. Patil, S., Melrose, J., and Chan, C. (2007) Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons, Eur. J. Neurosci., 26, 2131-2141.
79. Babenko, N. A., Semenova, Ya. A., and Kharchenko, V. S. (2009) Influence of fat-enriched diet on the level of sphingolipids and cognitive functions in old rats, Neirofiziologiya, 41, 309-315.
80. Canaan, A., DeFuriab, J., Perelmanc E., Schultzd, V., Seaya, M., Tucke, D., Flavellf, R. A., Snyderg, M. P., Obinb, M. S., and Weissman, S. M. (2014) Extended lifespan and reduced adiposity in mice lacking the FAT10 gene, PNAS, 111, 5313-5318.
81. Titov, V. N. (2011) Biological basics of evolution in cardiology - paracrine communities, cardiovascular system, biological functions and biological reactions, Ross. Kardiol. Zh., 6, 76-89.
82. Fessler, M. B., Rudel, L. L., and Brown, M. (2009) Toll- like receptor signaling links dietary fatty acids to the metabolic syndrome, Curr. Opin. Lipidol., 20, 379-385.
83. Lee, C. G., Ren, J., Cheong, I. S., Ban, K. H., Ooi, L. L., Yong, T. S., Kan, A., Nuchprayoon, I., Jin, R., Lee, K. H., Choti, M., and Lee, L. A. (2003) Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers, Oncogene, 22, 2592-2603.
84. Liao, C. Y., Rikke, B. A., Johnson, T. E., Gelfond, J. A., Diaz, V., and Nelson, J. F. (2011) Fat maintenance is a predictor of the murine lifespan response to dietary restriction, Aging Cell, 10, 629-639.
85. Sanz, P. (2008) AMP-activated protein kinase: structure and regulation, Curr. Protein Pept. Sci., 9, 478-492.
86. Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., and Smith, S. R. (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle, Diabetes, 54, 1926-1933.
87. Kowald, A. (1999) The mitochondrial theory of aging: do damaged mitochondria accumulate by delayed degradation? Exp. Gerontol., 34, 605-612.
88. De Grey, A. D. (1997) A proposed refinement of the mitochondrial free radical theory of aging, Bioessays, 19, 161-166.
89. Klionsky, D. J. (2007) Autophagy: from phenomenology to molecular understanding in less than a decade, Nat. Rev. Mol. Cell Biol., 8, 931-937.
90. Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Foretz, M., and Viollet, B. (2011) Antagonistic control of muscle cell size by AMPK and mTORC1, Cell Cycle, 10, 2640-2646.
91. Pes, G. M., Lio, D., Carru, C., Deiana, L., Baggio, G., Franceschi, C., Ferrucci, L., Oliveri, F., Scola, L., Crivello, A., Candore, G., Colonna-Romano, G., and Caruso, C. (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians, Aging Clin. Exp. Res., 16, 244-248.
92. Van Exel, E., Gussekloo, J., de Craen, A. J., Frolich, M., Bootsma-van der Wiel, A., and Westendorp, R. G. (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus study, Diabetes, 51, 1088-1092.
93. Chen, C. C., and Manning, A. M. (1996) TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells, Cytokine, 8, 58-65.
94. Corradin, S. B., Fasel, N., Buchmuller-Rouiller, Y., Ransijn, A., Smith, J., and Mauel, J. (1993) Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10, Eur. J. Immunol., 23, 2045-2048.
95. Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., and Cai, D. (2013) Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH, Nature, 497, 211-216.
96. Cai, D., and Liu, T. (2012) Inflammatory cause of metabolic syndrome via brain stress and NF-κB, Aging (Albany NY), 4, 98-115.
97. Purkayastha, S., Zhang, G., and Cai, D. (2011) Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-βand NF-κB, Nat. Med., 17, 883-887.
98. Burnstock, G. (2006) Historical review: ATP as a neuro-transmitter, Trends Pharmacol. Sci., 27, 166-176.
99. Burnstock, G. (2007) Physiology and pathophysiology of purinergic neurotransmission, Physiol. Rev., 87, 659-797.
100. Blagosklonny, M. V., and Hall, M. N. (2009) Growth and aging: a common molecular mechanism, Aging (Albany NY), 1, 357-362.
101. Blagosklonny, M. V. (2013) M(o)TOR of aging: MTOR as a universal molecular hypothalamus, Aging (Albany NY), 5, 490-494.
102. Qiang, W., Weiqiang, K., Qing, Z., Pengju, Z., and Yi, L. (2007) Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα, Exp. Mol. Med., 39, 535-543.
103. Schaeffler, A., Gross, P., Buettner, R., Bollheimer, C., Buechler, C., Neumeier, M., Kopp, A., Schoelmerich, J., and Falk, W. (2009) Fatty acid-induced induction of Toll- like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signaling with innate immunity, Immunology, 126, 233-245.
104. Terman, A., Kurz, T., Navratil, M., Arriaga, E. A., and Brunk, U. T. (2010) Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging, Antioxid. Redox Signal., 12, 503-535.
105. Mao, L., and Franke, J. (2013) Hormesis in aging and neurodegeneration - a prodigy awaiting dissection, J. Mol. Sci., 14, 13109-13128.
106. Mattson, M. (2008) Dietary factors, hormesis and health, Ageing Res. Rev., 7, 43-48.
107. Marques-Aleixo, I., Oliveira, P. J., Moreira, P. I., Magalhaes, J., and Ascensao, A. (2012) Physical exercise as a possible strategy for brain protection: evidence from mitochondrial-mediated mechanisms, Prog. Neurobiol., 99, 149-162.
108. Drapkina, O. M., and Chaparkina, S. O. (2007) Interrelationships between metabolic syndrome, aseptic inflammation and endothelium dysfunction, Ross. Med. Vesti, 3, 67-75.
109. Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., and Smith, S. R. (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle, Diabetes, 54, 1926-1933.
110. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R., and Mandarino, L. J. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466-8471.